Phio Pharmaceutical

-$0.02 (-1.09%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PHIO and other ETFs, options, and stocks.

About PHIO

Phio Pharmaceuticals Corp. is a biotechnology company, which engages in the development of immuno-oncology therapeutics that addresses unmet medical needs. Its clinical product candidate includes RXI-109, an RNAi compound developed for the reduction of dermal scarring in planned surgeries.

CEO
Gerrit Dispersyn
Employees
10
Headquarters
Marlborough, Massachusetts
Founded
2011

PHIO Key Statistics

Market Cap
28.96M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
516.58K
High Today
$1.85
Low Today
$1.80
Open Price
$1.83
Volume
67.61K
52 Week High
$4.36
52 Week Low
$1.72

PHIO Earnings

-$4.69
-$3.13
-$1.56
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 11, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure